Find a Tender
complete
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Cardiff University: "AMPA PH1 Drug Substance". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Cardiff University | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Cardiff University
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Cardiff University. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 121 active published awards; 119 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityCardiff University | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published26 Apr 2022, 09:17 BST | Last source update26 Apr 2022, 09:17 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-02b4bf | ||
What is being bought
The manufacture and production of the Active Pharmaceutical Ingredients
What changed
From the official release history
- Official notice release published
26 Apr 2022, 09:17 BST - Status changed to complete
25 May 2021, 12:35 BST - Official notice release published
25 May 2021, 12:35 BST - Buyer information updated
25 May 2021, 12:35 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe manufacture and production of the Active Pharmaceutical Ingredients for the purposes of the AMPA Trial, are products which are being manufactured purely for research purposesContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
26 Apr 2022, 09:17 BST - Award active
Not published · Not published - Contract active
Signed 25 May 2021, 00:00 BST · £571,000
Commercial outcome and competition
Awards Aptuit Not published · Not published · active |
Contracts Contract £571,000 · signed 25 May 2021, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) electronicBids: 1 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 1 (lot 1) smeBids: 1 (lot 1) |
Buyer and organisations in this procedure
Cardiff University
Contracting authority GB-FTS-1902Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe manufacture and production of the Active Pharmaceutical Ingredients for the purposes of the AMPA Trial, are products which are being manufactured purely for research purposes. With such research products as manufactured to GMP are intended to be solely used in the academic led clinical trial, known with Clinical Trial Acronym AMPA and in respect of the AMPA Trial Cardiff University is the academic Sponsor. With Sponsor being as is defined in the Research Governance Framework for Health and Social Care Research 2020. |